Nine Entos Team members among the #COVIDisAirborne team that is selected as Gordon Bell Finalists and featured in The New York Times
Chao's recruitment heralds the transition of Entos from a discovery-stage to a clinical-stage AI-driven biotech
Entos selected by Forbes Magazine for 2022 list of groundbreaking artificial intelligence companies
Nick brings 35 years of R&D experience across a broad spectrum of therapeutic areas and modalities